Onderneming RELIEF THERAPEUTICS Holding SA CINNOBER BOAT
Aandelen
0QKQ
CH0100191136
Biotechnologie & Medisch Onderzoek
Vakgebied
Verkoop per activiteit
CHF in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Biopharmaceutical Products
100,0
%
| 6 | 100,0 % | 6 | 100,0 % | -0,79% |
Verkoop per regio
CHF in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Europe (excluding Switzerland)
47,8
%
| 2 | 39,7 % | 3 | 47,8 % | +19,65% |
North America
23,3
%
| 2 | 27,9 % | 1 | 23,3 % | -17,25% |
Rest of the World
22,0
%
| 1 | 19,2 % | 1 | 22,0 % | +13,42% |
Switzerland
6,9
%
| 1 | 13,2 % | 0 | 6,9 % | -48,25% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Michelle Lock
CEO | Chief Executive Officer | - | 28-01-22 |
Jeremy Meinen
DFI | Director of Finance/CFO | - | - |
Ram Selvaraju
CHM | Chairman | 46 | 25-05-16 |
Paolo Galfetti
COO | Chief Operating Officer | - | 27-05-21 |
Anthony M. Kim
PRN | Corporate Officer/Principal | - | 01-12-21 |
Marco Marotta
PRN | Corporate Officer/Principal | - | 30-11-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ram Selvaraju
CHM | Chairman | 46 | 25-05-16 |
Paolo Galfetti
COO | Chief Operating Officer | - | 27-05-21 |
Thomas Plitz
BRD | Director/Board Member | 56 | 17-12-20 |
Patrice Jean
BRD | Director/Board Member | - | 27-05-21 |
Michelle Lock
CEO | Chief Executive Officer | - | 28-01-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 14 040 837 | 9 248 182 ( 65,87 %) | 1 822 398 ( 12,98 %) | 65,87 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
1 822 398 | 12.98% | 2 630 303 $ |
Bedrijfsgegevens
RELIEF THERAPEUTICS Holding SA
Avenue de Sécheron 15 Bâtiment F2/F3
1202, Geneva
+
http://www.relieftherapeutics.comSector
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+25,69% | 47,86 mld. | |
+46,90% | 41,42 mld. | |
-3,46% | 40,66 mld. | |
-6,20% | 28,92 mld. | |
+9,17% | 25,55 mld. | |
-20,42% | 19,27 mld. | |
+0,17% | 12,15 mld. | |
+28,07% | 12,14 mld. | |
-1,24% | 11,99 mld. |